ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
Nothofagus
|
61 |
10K |
6 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
61
|
10K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
17 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
17
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
13 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
12K
|
4.5M
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
Nothofagus
|
148 |
31K |
12 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
148
|
31K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
Nothofagus
|
148 |
31K |
4 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
148
|
31K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
12K
|
4.5M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
12K
|
4.5M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
12K
|
4.5M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
should see 60c soon
|
|
Nothofagus
|
11 |
8.0K |
8 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
11
|
8.0K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust reappoints MD and resets its sights on MND battle
|
|
Nothofagus
|
15 |
4.6K |
4 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
15
|
4.6K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Sp trajectory post approval
|
|
Nothofagus
|
22 |
12K |
8 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
22
|
12K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Nothofagus
|
510 |
117K |
15 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
510
|
117K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Registered Office and Principal Place of Business
|
|
Nothofagus
|
17 |
4.3K |
8 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
17
|
4.3K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
20 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
12K
|
4.5M
|
20
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
11 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
12K
|
4.5M
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Registered Office and Principal Place of Business
|
|
Nothofagus
|
17 |
4.3K |
7 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
17
|
4.3K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
9 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
9
|
|
ASX - By Stock
|
EOF |
Re:
Ann: Update on Ecofibre Advanced Technologies Inc.
|
|
Nothofagus
|
10 |
3.2K |
0 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
10
|
3.2K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Sp trajectory post approval
|
|
Nothofagus
|
22 |
12K |
6 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
22
|
12K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
should see 60c soon
|
|
Nothofagus
|
11 |
8.0K |
10 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
11
|
8.0K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
6 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Nothofagus
|
510 |
117K |
16 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
510
|
117K
|
16
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
7 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
16 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
16
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Post Approval Takeover Predictions
|
|
Nothofagus
|
65 |
28K |
14 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
65
|
28K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
12 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
12K
|
4.5M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
12K
|
4.5M
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Nothofagus
|
58 |
15K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
58
|
15K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Post Approval Takeover Predictions
|
|
Nothofagus
|
65 |
28K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
65
|
28K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Post Approval Takeover Predictions
|
|
Nothofagus
|
65 |
28K |
15 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
65
|
28K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Nothofagus
|
510 |
117K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
510
|
117K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Nothofagus
|
510 |
117K |
7 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
510
|
117K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Nothofagus
|
510 |
117K |
4 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
510
|
117K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Nothofagus
|
58 |
15K |
5 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
58
|
15K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Nothofagus
|
86 |
20K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Nothofagus
|
86 |
20K |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Nothofagus
|
86 |
20K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Nothofagus
|
86 |
20K |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Nothofagus
|
510 |
117K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
510
|
117K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Nothofagus
|
86 |
20K |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Nothofagus
|
255 |
93K |
15 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
255
|
93K
|
15
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Nothofagus
|
8.6K |
3.2M |
6 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
8.6K
|
3.2M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Nothofagus
|
255 |
93K |
12 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
93K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Nothofagus
|
255 |
93K |
8 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
93K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Nothofagus
|
255 |
93K |
7 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
93K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Nothofagus
|
255 |
93K |
10 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
93K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Nothofagus
|
12K |
4.5M |
15 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
12K
|
4.5M
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
Nothofagus
|
42 |
9.4K |
13 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
42
|
9.4K
|
13
|
|